×
For best experience we recommend to activate Javascript in your browser.
SEC14L4 antibody (N-Term)
This Rabbit Polyclonal antibody specifically detects SEC14L4 in ELISA, WB and IHC. It exhibits reactivity toward Human.
Catalog No. ABIN2357155
$920.00
Plus shipping costs $50.00
Delivery in 11 to 17 Business Days
Quick Overview for SEC14L4 antibody (N-Term) (ABIN2357155)
Target
See all SEC14L4 Antibodies
SEC14L4
(SEC14-Like 4 (SEC14L4))
Reactivity
All reactivities for SEC14L4 antibodies
Human
Host
All hosts for SEC14L4 antibodies
Rabbit
Clonality
All clonalities for SEC14L4 antibodies
Polyclonal
Conjugate
All conjugates for SEC14L4 antibodies
This SEC14L4 antibody is un-conjugated
Application
All applications for SEC14L4 antibodies
ELISA, Western Blotting (WB), Immunohistochemistry (IHC)
Product Details anti-SEC14L4 Antibody
(hide)
Binding Specificity
All epitopes for SEC14L4 antibodies
AA 40-70, N-Term
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
SEC14L4, NT (SEC14L4, TAP3, SEC14-like protein 4, Tocopherol-associated protein 3)
Purification
Purified by Protein A affinity chromatography.
Immunogen
SEC14L4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 40-70 amino acids from the N-terminal region of human SEC14L4.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for SEC14L4
(hide)
Target
SEC14L4
(SEC14-Like 4 (SEC14L4))
Alternative Name
SEC14L4
NCBI Accession
NP_777637
UniProt
Q9UDX3
Recently viewed
(hide)
You are here:
Homepage
anti-SEC14L4 antibody (N-Term) (ABIN2357155)
Chat with us , powered by LiveChat